The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Explore the innovative generative AI method transforming drug discovery and material science at unprecedented speeds.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Computational drug discovery and design embodies the integration of advanced computational methods, machine learning, and cheminformatics to streamline the identification and optimisation of ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.

Nvidia is no longer content to be the chip supplier behind other companies’ biotech ambitions. With a multibillion dollar ...

TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...

Traditionally, developing a new drug takes many years and requires a massive financial investment, often involving significant risk and a high likelihood of failure. AI models trained on extensive ...

Veeva Systems markets a suite of software services geared toward the biopharmaceutical industry. A wholly owned customer relationship management service is gaining steam for Veeva Systems. With access ...